US-China Biomedical Technology, Inc. announced earnings results for the first quarter ended May 31, 2019. For the first quarter, the company announced operating loss was USD 122,196 compared to USD 86,593 a year ago. Net loss was USD 122,703 compared to USD 274,645 a year ago. Basic earnings per share from continuing operations was USD 0.01 compared to USD 0.02 a year ago.